Cantor Fitzgerald’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-81,966
Closed -$1.2M 760
2023
Q1
$1.2M Hold
81,966
0.03% 356
2022
Q4
$598K Hold
81,966
0.01% 443
2022
Q3
$567K Sell
81,966
-19
-0% -$142 0.01% 490
2022
Q2
$573K Sell
81,985
-20,000
-20% -$156K 0.01% 539
2022
Q1
$843K Buy
101,985
+22,019
+28% +$199K 0.06% 204
2021
Q4
$864K Buy
+79,966
New +$863K 0.06% 211

Cantor Fitzgerald's AMYT Position: Q2 2023 in Review

Cantor Fitzgerald sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 81,966 shares — an estimated $1.2M sold.

Cantor Fitzgerald first reported a position in AMYT in Q4 2021 and held it in 6 quarters. The position peaked at $1.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Cantor Fitzgerald reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 81,966 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $1.2M.
  • Cantor Fitzgerald first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 6 quarters.
  • Cantor Fitzgerald's Amryt Pharma plc American Depositary Shares position peaked at $1.2M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.